EFFICACY OF INDUCTION UPADACITINIB THERAPY IN EAST ASIAN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
Minhu Chen 1
Gao Xiang 2
Kenji Watanabe 3
Toshimitsu Fujii 4
Jae Hee Cheon 5
Shu Chen Wei 6
Dennis Teng 7
Ana Paula Machado De Lacerda 7
Valencia Remple 7
Hiroshi Nakase 8
1 The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
2 The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
3 Hyogo Medical University, Nishinomiya, Japan
4 Tokyo Medical and Dental University, Tokyo, Japan
5 Yonsei University, Seoul, Korea, Republic of
6 National Taiwan University Hospital, Taipei, Taiwan, Province of China
7 AbbVie Inc., North Chicago, United States
8 Sapporo Medical University, Sapporo, Japan
Topic
IBD
Session
PP 05 IBD (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]